Cure My Disease

Don't miss your cure!

 Log in / Sign up

New lupus drug RO7507062 enters first human safety trial

NCT ID NCT05835986

Ongoing Disease control Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests a new drug called RO7507062 in 70 people with systemic lupus erythematosus (SLE). The main goal is to check its safety and how the body processes it. Participants receive the drug as a shot under the skin, and the study will look for side effects and measure drug levels in the blood.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
RO7507062
What this could lead to
If this drug is safe and shows promise, it could lead to a new treatment option for people with systemic lupus erythematosus.
What could go wrong
This is a very early, first-in-human study focused on safety, not effectiveness. The drug may not work or could have unexpected side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SYSTEMIC LUPUS ERYTHEMATOSUS

Contacts and locations

Locations

  • CREA Hospital Mexico Americano

    Guadalajara, Jalisco, 44620, Mexico

  • Centre For Human Drug Research

    Leiden, 2333, Netherlands

  • Chang Gung Medical Foundation - Linkou

    Taoyuan, 333, Taiwan

  • Charité Research Organisation GmbH

    Berlin, 10117, Germany

  • Chung Shan Medical University Hospital

    Taichung, 40201, Taiwan

  • Clinica De La Costa

    Barranquilla, 080020, Colombia

  • Clínica San Juan Bautista CSJB

    Lima, 15431, Peru

  • FARMOVS (Pty) Ltd

    Bloemfontein, 9301, South Africa

  • Groupe Hospitalier Pitie-Salpetriere

    Paris, 75651, France

  • Hospital Angeles De Lindavista

    Mexico City, Mexico CITY (federal District), 07760, Mexico

  • Hospital General De Mexico

    Mexico City, Mexico CITY (federal District), 6726, Mexico

  • Hospital General Universitario Gregorio Marañon

    Madrid, 28007, Spain

  • Hospital Pablo Tobon Uribe

    Medellín, 050034, Colombia

  • Hospital Umum Sarawak

    Kuching, 93586, Malaysia

  • Hospital Universitario 12 de Octubre

    Madrid, 28041, Spain

  • Hospital Universitario Reina Sofia

    Córdoba, 14004, Spain

  • Hôpital Saint Eloi

    Montpellier, 34295, France

  • Oncomedica S.A.

    Montería, 230002, Colombia

  • Ramathibodi Hospital, Mahidol Uni

    Bangkok, 10400, Thailand

  • UCL Hospital NHS Trust

    London, NW1 2PG, United Kingdom

  • Universitätsklinikum Duesseldorf

    Düsseldorf, 40225, Germany

  • Uniwersytecki Szpital Kliniczny w Poznaniu

    Późna, 61-848, Poland

  • Wojskowy Instytut Medyczny- Panstwowy Instytut Badawczy

    Warsaw, 04-141, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.